Optimization and validation of an ELISA assay for the determination of antibody responses to CN54gp140 and AIDSVAX BE for use in the Phase IIb PrEPVacc vaccine trial. S1 Data
Gombe, B, Streatfield, C, Leal, L, Opio, S, Joseph, S, Weber, J, Hare, J
, Kaleebu, P and Serwanga, J
(2022).
Optimization and validation of an ELISA assay for the determination of antibody responses to CN54gp140 and AIDSVAX BE for use in the Phase IIb PrEPVacc vaccine trial. S1 Data.
[Dataset].
PLOS ONE.
https://doi.org/10.1371/journal.pone.0275927.s001
, Kaleebu, P and Serwanga, J
(2022).
Optimization and validation of an ELISA assay for the determination of antibody responses to CN54gp140 and AIDSVAX BE for use in the Phase IIb PrEPVacc vaccine trial. S1 Data.
[Dataset].
PLOS ONE.
https://doi.org/10.1371/journal.pone.0275927.s001
Data supporting the analyses outlined in "Optimization and validation of an ELISA assay for the determination of antibody responses to CN54gp140 and AIDSVAX BE for use in the Phase IIb PrEPVacc vaccine trial".
Keywords
Enzyme-linked immunoassays, Antibodies, HIV vaccines, Vaccine development, HIV, Coatings, Viral vaccines, Virus testing| Item Type | Dataset |
|---|---|
| Capture method | Unknown |
| Date | 3 November 2022 |
| Language(s) of written materials | English |
| Creator(s) |
Gombe, B, Streatfield, C, Leal, L, Opio, S, Joseph, S, Weber, J, Hare, J, Kaleebu, P and Serwanga, J
|
| LSHTM Faculty/Department | MRC/UVRI and LSHTM Uganda Research Unit |
| Participating Institutions | London School of Hygiene & Tropical Medicine, London, United Kingdom |
| Date Deposited | 09 Dec 2022 11:41 |
| Last Modified | 09 Dec 2022 11:41 |
| Publisher | PLOS ONE |
No files available. Please consult associated links.
Downloads
